Quest Diagnostics Inc (NYSE:DGX)
$ 144.17 -0.17 (-0.12%) Market Cap: 16.02 Bil Enterprise Value: 20.89 Bil PE Ratio: 19.40 PB Ratio: 2.49 GF Score: 82/100

Quest Diagnostics Inc at Barclays Global Healthcare Conference Transcript

Mar 10, 2020 / 01:30PM GMT
Release Date Price: $106.34 (-3.19%)
Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Good morning, and welcome to our second presentation from the Barclays Virtual HealthCare Conference. Really pleased to be joined this morning with Quest Diagnostics' CFO, Mark Guinan, as well as Head of Investor Relations, Shawn Bevec. And hoping to get through these questions over 25 minutes.

Questions & Answers

Jack Meehan
Barclays Bank PLC, Research Division - VP & Senior Research Analyst

Just wanted to start, Mark, with the here and now. Obviously, the topic de jure has been the coronavirus. I was curious if you could weigh in just how you expect this to impact the business and demand for testing services and have you seen any increased testing rates so far related to the new test.

Mark J. Guinan
Quest Diagnostics Incorporated - Executive VP & CFO

Right. Thanks for the question, Jack, and pleasure to be on the phone here. What we've shared publicly is that we started yesterday with specimens collected

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot